TCM
LABU icon

Traynor Capital Management’s Direxion Daily S&P Biotech Bull 3X Shares LABU Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,586
Closed -$773K 257
2024
Q4
$773K Sell
8,586
-2,177
-20% -$196K 0.05% 105
2024
Q3
$1.39M Buy
10,763
+674
+7% +$86.8K 0.08% 82
2024
Q2
$1.14M Buy
10,089
+4,285
+74% +$486K 0.09% 83
2024
Q1
$770K Buy
5,804
+3,142
+118% +$417K 0.07% 103
2023
Q4
$325K Buy
+2,662
New +$325K 0.03% 151
2022
Q2
Sell
-152,290
Closed -$2.39M 199
2022
Q1
$2.39M Buy
152,290
+116,929
+331% +$1.83M 0.31% 52
2021
Q4
$1.27M Buy
35,361
+25,967
+276% +$935K 0.15% 76
2021
Q3
$519K Buy
9,394
+580
+7% +$32K 0.07% 119
2021
Q2
$662K Buy
8,814
+391
+5% +$29.4K 0.09% 98
2021
Q1
$664K Sell
8,423
-1,219
-13% -$96.1K 0.11% 93
2020
Q4
$968K Sell
9,642
-4,535
-32% -$455K 0.17% 72
2020
Q3
$871K Sell
14,177
-979
-6% -$60.1K 0.2% 66
2020
Q2
$900K Buy
15,156
+6,080
+67% +$361K 0.22% 63
2020
Q1
$204K Sell
9,076
-23,531
-72% -$529K 0.07% 114
2019
Q4
$1.87M Buy
32,607
+12,183
+60% +$700K 0.5% 45
2019
Q3
$631K Buy
20,424
+6,100
+43% +$188K 0.2% 88
2019
Q2
$729K Buy
14,324
+2,595
+22% +$132K 0.24% 76
2019
Q1
$702K Buy
11,729
+421
+4% +$25.2K 0.24% 72
2018
Q4
$371K Buy
11,308
+5,924
+110% +$194K 0.15% 94
2018
Q3
$501K Sell
5,384
-100
-2% -$9.31K 0.16% 88
2018
Q2
$535K Buy
+5,484
New +$535K 0.2% 81
2018
Q1
Sell
-9,932
Closed -$773K 184
2017
Q4
$773K Sell
9,932
-5,950
-37% -$463K 0.33% 60
2017
Q3
$1.33M Sell
15,882
-2,604
-14% -$218K 0.63% 38
2017
Q2
$1.22M Buy
18,486
+12,107
+190% +$800K 0.6% 36
2017
Q1
$322K Sell
6,379
-73,043
-92% -$3.69M 0.18% 106
2016
Q4
$2.85M Buy
79,422
+22,587
+40% +$809K 1.89% 10
2016
Q3
$1.91M Buy
56,835
+9,140
+19% +$307K 1.35% 18
2016
Q2
$1.42M Buy
47,695
+35,558
+293% +$1.06M 1.11% 21
2016
Q1
$332K Sell
12,137
-42,498
-78% -$1.16M 0.26% 80
2015
Q4
$1.15M Buy
+54,635
New +$1.15M 0.83% 28